CAMBRIDGE, Mass. (AP) — In a story Jan. 11 about Vertex Pharmaceuticals Inc. and its hepatitis C drug, The Associated Press misstated when the company will seek regulatory approval for the drug. Approval will be requested in the second half of 2010, not 2009.
Correction: Vertex Hepatis C Drug
admin
Contributor
Font Size: